Work

Supplementary Figure from ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure from ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361941985
Cites:
Cited by:
Related to: 10